Welcome

Vital Signs Market

1-10 of 308

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. Vital Signs The Analyst's Perspective - July 2016 Issue

    Vital Signs The Analyst's Perspective - July 2016 Issue

    Release Date : 30-Aug-2016 Region : Global
    This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.
    USD 600

    read more

  2. Vital Signs The Analyst's Perspective - June 2016 Issue

    Vital Signs The Analyst's Perspective - June 2016 Issue

    Release Date : 02-Aug-2016 Region : Global
    This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.
    USD 450

    read more

  3. Vital Signs The Analyst's Perspective - May 2016 Issue

    Vital Signs The Analyst's Perspective - May 2016 Issue

    Release Date : 30-Jun-2016 Region : Global
    This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.
    USD 450

    read more

  4. Vital Signs The Analyst's Perspective - April 2016 Issue

    Vital Signs The Analyst's Perspective - April 2016 Issue

    Release Date : 24-May-2016 Region : Global
    This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.
    USD 450

    read more

  5. Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016

    Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016

    Exciting Developments in Generic Drug Pricing, CRISPR Technology, GenomeAsia 100K and Large-scale Next-generation Sequencing Projects, and Medicare Outcomes

    Release Date : 04-Apr-2016 Region : Global
    This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.
    USD 450

    read more

  6. Vital Signs - Impact on Medical Imaging of Deep Learning and Internet of Things (IoT), HIMSS 2016

    Vital Signs - Impact on Medical Imaging of Deep Learning and Internet of Things (IoT), HIMSS 2016

    Competitive Strategies and Time to Market are Key to Maximizing on Emerging Growth Opportunities

    Release Date : 24-Mar-2016 Region : North America
    As every year, Frost & Sullivan attended the annual HIMSS meeting, where we explore new trending themes unveiling new opportunities in medical imaging. The two themes pertaining to medical imaging that we explored at the 2016 edition are: I. The Internet of Medical Imaging Things: Assessing the Stra...
    USD 750

    read more

  7. Vital Signs - Drug Development Focus on Genetically Modified Swine

    Vital Signs - Drug Development Focus on Genetically Modified Swine

    Modified Swine Hold out Promise of Improving Pre-Clinical Efficacy, Lowering Multi-billion Dollar Drug and Device Development Costs

    Release Date : 18-Mar-2016 Region : North America
    The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that mor...
    USD 450

    read more

  8. Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery

    Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery

    Additional Clinical Trials Critical to Building on Early Promise

    Release Date : 18-Mar-2016 Region : North America
    As indicated by the World Health Organization, stroke is the second-leading cause of death for people over the age of 60 and is the fifth-leading cause of death for those between the ages of 15 and 59. The incidence of stroke is expected to increase by 25% over the next 20 years. Over 40% of ischemi...
    USD 450

    read more

  9. Vital Signs - Impact of Strategic Acquisitions on Life Sciences Market, 2016

    Vital Signs - Impact of Strategic Acquisitions on Life Sciences Market, 2016

    Portfolio Expansions Follow Acquisitions by Panasonic Healthcare Holdings Co.,Thermo Fisher Scientific and Abbott Laboratories

    Release Date : 12-Feb-2016 Region : Global
    This Vital Signs issues discusses Panasonic Healthcare's completed acquisition of Bayer's Diabetes Care Unit, Thermo Fisher Scientific's acquisition of Affymetrix, several moves in the single cell-genomics market by Bio-Rad, Illumina, Qiagen, and 10x Genomics, and Abbott's acquisition of Alere.
    USD 450

    read more

  10. Vital Signs - Technology Developments in Medical Imaging Markets, Radiological Society of North America (RSNA) Meeting 2015

    Vital Signs - Technology Developments in Medical Imaging Markets, Radiological Society of North America (RSNA) Meeting 2015

    Medical 3D Printing and Medical Imaging Equipment Asset Management Services, Advanced Enterprise Imaging Informatics Seek to Capture Growth Opportunities

    Release Date : 10-Feb-2016 Region : North America
    \ Frost & Sullivan attended the annual meeting of the Radiological society of North America (RSNA). The four themes we have developed in our coverage of the 2015 edition fall under the topic areas of:\ I- Competitive Landscape and New Business Models, looking at new entrants in the capital imaging...
    USD 750

    read more

1-10 of 308

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5